BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 5,570.00
+70.00 (1.27%)
At close: Nov 26, 2025
BioNote Market Cap
BioNote has a market cap or net worth of 564.58 billion as of November 26, 2025. Its market cap has increased by 18.84% in one year.
Market Cap
564.58B
Enterprise Value
218.11B
Revenue
115.09B
Ranking
n/a
PE Ratio
4.80
Stock Price
5,570.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 564.58B, a decrease of -47.96%. That is a compound annual growth rate of -19.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 564.58B | 17.45% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.81T |
| Celltrion | 39.84T |
| ALTEOGEN | 28.19T |
| SK Biopharmaceuticals | 10.05T |
| ABL Bio | 9.54T |
| Yuhan | 8.60T |
| Peptron | 7.30T |
| LigaChem Biosciences | 6.25T |